A
$ Value
$0
Shares
215
Price
$0
Filed
Mar 11
Insider
Name
WENTWORTH TIMOTHY C
Title
—
CIK
0001252016
Roles
Director
Transaction Details
Transaction Date
2026-03-09
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
215
Footnotes
Represents an award of restricted stock units.
Filing Info
WENTWORTH TIMOTHY C's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | DGX | A | $0 |
| 2026-03-09 | DGX | A | $0 |
| 2025-08-28 | WBA | D | — |
Other Insiders at DGX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CARTER ROBERT B | — | — | 2026-01-28 |
|
PREVOZNIK MICHAEL E
SVP & General Counsel
|
— | $1.1M | 2026-03-05 |
| WENTWORTH TIMOTHY C | — | — | 2026-04-01 |
|
Plewman Patrick
SVP for Diagnostic Services
|
— | $2.0M | 2026-03-05 |
| Gregg Vicky B | — | — | 2026-01-28 |
|
Doherty Catherine T.
EVP, Regional Businesses
|
— | $7.0M | 2026-03-05 |
|
Davis J. E.
CEO and President
|
— | $2.1M | 2026-03-04 |
|
SAMAD SAM
Executive Vice President & CFO
|
— | — | 2026-03-04 |
|
Deppe Michael J
SVP, Corp. Controller & CAO
|
— | — | 2026-03-04 |
| Lassiter Wright III | — | — | 2026-01-28 |
|
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
|
— | $538K | 2026-03-04 |
|
DELANEY MARK E
SVP & Chief Commercial Officer
|
— | — | 2026-03-04 |